Clinical Research Directory
Browse clinical research sites, groups, and studies.
Defining the Genetics, Biomarkers and Outcomes for Dilated Cardiomyopathy
Sponsor: Imperial College London
Summary
Finding new ways to diagnose and treat Dilated Cardiomyopathy (DCM) could improve the health and well-being of patients with this condition. The main aim of this research study is to help develop better ways of diagnosing and treating patients with DCM. The information that is collected may help develop tailored treatments for patients with this disease in the future. This research study will recruit patients with DCM from a number of centres across England and follow their health over a period of years. Patients will give some blood samples for a type of genetic test called whole genome sequencing (WGS) to look for genetic changes. Patients will also have a magnetic resonance imaging (MRI) scan of their heart to look for any changes in the heart such as scarring, and check their heart function. The aim of this study is to discover if using WGS and MRI can improve the diagnosis of DCM. Another aim of the study is to look at how genetic changes and scarring in the heart may affect the progress of the disease. Studying patients with DCM may also help the investigators learn more about diagnosing and treating other diseases of the heart. The second aim of this study is to see whether using WGS and MRI scanning can also be useful in other types of heart diseases which might be affected by genetic changes or scarring in the heart.
Official title: Defining the Genetics, Biomarkers and Outcomes for Dilated Cardiomyopathy: a Prospective Multi-centre Observational Study
Key Details
Gender
All
Age Range
Any - 99 Years
Study Type
OBSERVATIONAL
Enrollment
2000
Start Date
2020-01-09
Completion Date
2029-06-16
Last Updated
2026-03-27
Healthy Volunteers
No
Interventions
Part 1: DCM Cohort
Patients with a confirmed diagnosis of DCM will have samples that undergo whole genome sequencing and biomarker analysis
Part 2: Heritable CV Diseases and Family Members
Biomarker analysis will be undertaken on samples
Locations (6)
Leeds Teaching Hospitals NHS Trust
Leeds, United Kingdom
Glenfield Hospital
Leicester, United Kingdom
Liverpool Heart and Chest Hospital NHS Foundation Trust
Liverpool, United Kingdom
Royal Brompton & Harefield NHS Foundation Trust
London, United Kingdom
Oxford University Hospitals NHS Foundation Trust
Oxford, United Kingdom
Southampton General Hospital
Southampton, United Kingdom